Submitted by kzahs_258301 on Tue, 05/22/2018 - 5:55pm NCT03507790 CT1812 United States Thursday, May 31, 2018 – Saturday, November 30, 2019 24 Phase 2 Mild-to-Moderate AD Tuesday, May 22, 2018 Cognition Therapeutics Inc. Comments No Available Comments Make a Comment To make a comment you must login or register.
Submitted by kzahs_258301 on
Submitted by kzahs_258301 on
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.